The abstract is read at the publisher; the summary is JClub's.
In a double-blind crossover study of 19 healthy adults, acute guarana (1, 2, 4 mg*kg*bodyweight-1 caffeine) showed no significant dose-response on memory, reaction time, sustained attention, or inhibition versus matched caffeine or placebo.
- Why it matters: The acute dose-response of guarana for cognitive performance—and how it compares with caffeine—was unclear, limiting evidence for its purported cognitive benefits.
- What they did: Participants completed a baseline and five sessions on separate days, ingesting placebo, guarana at three caffeine-equivalent doses, or matched-dose caffeine (4 mg*kg*bw-1), then performed memory, reaction time, sustained attention, and inhibition tasks pre- and 30 minutes post-ingestion.
- The result: While session effects appeared for memory (p = 0.05) and sustained attention (p = 0.01), treatments and time interactions were not significant (p > 0.05), implying acute guarana is not linked to improved cognitive task performance under these conditions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.